Final results of ENLIVEN: A global, double-blind, randomized, placebo-controlled, phase 3 study of pexidartinib in advanced tenosynovial giant cell tumor (TGCT) Meeting Abstract
| Authors: | Tap, W. D.; Gelderblom, H.; Stacchiotti, S.; Palmerini, E.; Ferrari, S.; Desai, J.; Bauer, S.; Blay, J. Y.; Alcindor, T.; Ganjoo, K. N.; Broto, J. M.; Ryan, C. W.; Shuster, D. E.; Zhang, L.; Wang, Q.; Hsu, H.; Lin, P. S.; Tong, S.; Wagner, A. J. |
| Abstract Title: | Final results of ENLIVEN: A global, double-blind, randomized, placebo-controlled, phase 3 study of pexidartinib in advanced tenosynovial giant cell tumor (TGCT) |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 576s |
| Language: | English |
| ACCESSION: | WOS:000442916003585 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.11502 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 11502 -- Source: Wos |
